Pharmafile Logo
Pharmafocus logo
Advanced Search

Germany’s Merck pledges emphasis on women executives

February 14, 2011
Sales and Marketing Merck KGaA, Women in pharma, equality

Merck KGaA has set itself the goal of increasing its proportion of women managers over the next five years. The …

News

7 Wins for Pulsar!

February 11, 2011
Medical Communications, Sales and Marketing

Pulsar have done very well of late and managed to bag 1 silver Rx award and  6  New York Rx …

Feature
Thought Leadership
AstraZeneca's social media white paper

Digital Pharma: AZ presses the case for social media in pharma

February 11, 2011
Medical Communications AZ, AstraZeneca, Digital Pharma blog, FDA, social media

Seemingly fed up with waiting for the FDA’s delayed social media guidance, AstraZeneca has published details of its own feedback …

News

Shire thrives on specialist portfolio

February 11, 2011
Sales and Marketing 2010 pharma results, ADHD, Shire, Vyvanse

Speciality pharma company Shire has posted sales growth of 16%, led by its ADHD treatment Vyvanse. Sales of Vyvanse rose …

News

Pierre Fabre loses chief executive

February 11, 2011
Sales and Marketing Olivier Bohuon, Pierre Fabre, Smith & Nephew, appointment, medical devices, sales and marketing

Olivier Bohuon is leaving French pharma company Pierre Fabre after serving just five months as its chief executive. He will …

Appointment
ABPI Code of Practice

Cephalon in trouble over party spirit

February 11, 2011
Medical Communications ABPI, ABPI Code of Practice, Cephalon, PMCPA, industry reputation

Cephalon has been criticised by UK authorities for bankrolling “excessive” hospitality at a conference in Lisbon.The company was cited by …

News

TBWA Paling Walters adds to management board

February 11, 2011
Medical Communications Andy Hayley, Ed Shorthose, Steve Morris, TBWA/Paling Walters, appointment, medical communications

London-based advertising agency TBWA\ Paling Walters has promoted Steve Morris and Ed Shorthose to the roles of managing partners. They …

News
Eli Lilly chief executive John Lechleiter

Lilly chief issues warning on UK reforms

February 11, 2011
Research and Development, Sales and Marketing John Lechleiter, US health reforms, healthcare reform, lilly, patent box, value-based pricing

Lilly chief executive John Lechleiter has warned that two key UK initiatives could fall seriously short of encouraging investment in …

News

Innovation is being stifled – Lilly chief executive

February 10, 2011
Research and Development, Sales and Marketing Economist 2011 Pharma Summit, US health reforms, healthcare costs, healthcare reform, lilly

Supporting medical innovation should be a fundamental requirement of healthcare reforms, but current public policies are failing to do this, …

News
Blog footer

Digital Pharma: This is how pharma is using digital

February 10, 2011
Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Android, Digital Pharma blog, Facebook, Twitter, disease awareness campaigns, ipad, iphone, social media

Pharma’s use of digital tools, from mobile apps to online campaigns to social media channels, is increasing all the time …

Feature

Amarin expands US operations

February 10, 2011
Sales and Marketing AMR101, Amarin, Paul Huff, high cholesterol

Dublin-based biopharmaceutical company Amarin is to increase its US presence by setting up sales and marketing headquarters in New Jersey. …

News
GSK's swine flu vaccine Pandemrix

WHO wants narcolepsy link with swine flu vaccine investigated

February 10, 2011
Research and Development, Sales and Marketing Finland Institute, GSK, GlaxoSmithKline, Pandemrix, narcolepsy, swine flu

The World Health Organisation has called for further investigation into GSK’s swine flu vaccine link to sleeping disorder narcolepsy, following …

News

Dr Mikael von Euler moves to Oncos Therapeutics

February 10, 2011
Research and Development Dr Mikael von Euler, Oncos Therapeutics, appointment, research and development

Finnish biotech company Oncos Therapeutics has appointed Dr Mikael von Euler as chief medical officer. He has more than 20 …

Appointment

Alliance concerned over NHS competition reforms

February 10, 2011
Health and Social Care Bill, NHS, NHS Alliance, NHS reforms

The NHS Alliance has called on the Government to clarify major issues around the Health and Social Care Bill which …

News

Generics force Sanofi into standstill

February 9, 2011
Sales and Marketing 2010 pharma results, Jevtana, Multaq, Sanofi, Sanofi-Aventis, generics

An onslaught of generic competition combined with healthcare cuts in the US and Europe meant Sanofi-Aventis’ revenues were brought to …

News

Shire bags senior research execs from GSK and Abbott

February 9, 2011
Research and Development Dr Lawson Macartney, Dr Mario Saltarelli, Shire, appointment, recruitment, research and development

Shire has strengthened its speciality pharmaceuticals business with the appointment of senior research executives from GlaxoSmithKline and Abbott. Dr Lawson …

News
Diabetes injection

Pharma-NHS diabetes project begins

February 9, 2011
Sales and Marketing AstraZeneca, Lilly UK, MSD, NHS, Nottingham, Novartis, Novo Nordisk, Pfizer, Sanofi-Aventis, joint working

A joint venture between the NHS, charities and the pharma sector has begun in Nottingham to help treat the city’s …

News

Teva surges ahead

February 9, 2011
Sales and Marketing 2010 pharma results, Copaxone, Teva, Teva Pharmaceutical

Generics giant Teva enjoyed a strong year of growth in 2010, lifted by the acquisition of Ratiopharm, patent expiries of …

News

Dr Matthias joins Noxxon Pharma

February 9, 2011
Research and Development Dr Matthias Baumann, Noxxon Pharma, appointment, research and development

Berlin-based biotech Noxxon Pharma has appointed Dr Matthias Baumann as chief medical officers. He joins from Focus Clinical Drug Development, …

Appointment
Advanced melanoma

Melanoma: intense competition to be the next milestone treatment

February 9, 2011
Research and Development BRAF V600 mutation, Cancer, Tasigna, cancer research, melanoma, tremelimumab

A flurry of new data has emerged in the recent months from an industry-wide pipeline of cancer drugs which could …

Feature
The Gateway to Local Adoption Series

Latest content

Five Facts about spinal muscular atrophy

January 28, 2026

Sobi’s Aspaveli receives European Commission approval for treatment of two rare kidney diseases

January 28, 2026

Everdrone appoints David Borkmann as Senior Medical Advisor

January 28, 2026

MRM Health’s ulcerative colitis treatment receives FDA Investigational New Drug clearance

January 27, 2026

Crystalys Therapeutics appoints Justin Thacker as Chief Financial Officer

January 27, 2026